Rivanna Ultrasound for Neuraxial Block

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

April 13, 2019

Study Completion Date

April 13, 2019

Conditions
Analgesia
Interventions
DEVICE

Rivanna Accuro US Device

When the subject is ready for neuraxial procedure, the location for the epidural or spinal needle insertion will be identified with Rivanna Accuro U/S device. For subjects in group C-R or L-R, the needle insertion site will be the site identified by the Rivanna Accuro U/S device. After placement of spinal for Cesarean or epidural for labor, the usual standard dose of medication will be administered as in usual manner for patients regardless in this study or not.

OTHER

Palpation

When the subject is ready for neuraxial procedure, the location for the epidural or spinal needle insertion will be identified with Palpation method using conventional landmarks (spinous process and iliac crest). For subjects in group C-P or L-P, the needle insertion site will be the site identified by the Palpation method. After placement of spinal for Cesarean or epidural for labor, the usual standard dose of medication will be administered as in usual manner for patients regardless in this study or not.

PROCEDURE

Neuraxial Analgesia

Labor analgesia will be provided utilizing the standard medications to provide labor analgesia

PROCEDURE

Spinal Block

Spinal anesthetic medications will be utilized in providing surgical block for cesarean delivery as is standard of care

Trial Locations (1)

27103

Novant Health Forsyth Medical Center, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03214640 - Rivanna Ultrasound for Neuraxial Block | Biotech Hunter | Biotech Hunter